During the past decade, Anand Multispeciality Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anand Multispeciality Hospital" #1 collaborator was "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Anand Multispeciality Hospital" are "Non-valvular Atrial Fibrillation (NVAF)" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Anand Multispeciality Hospital" in a lesser frequency.

Most popular intervention types in "Anand Multispeciality Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Diclofenac sodium gel 1%" (1 trials), "Placebo gel" (1 trials), "Rivaroxaban (Xarelto,Bay 59-7939)" (1 trials) and "Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anand Multispeciality Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Anand Multispeciality Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Anand Multispeciality Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Anand Multispeciality Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".